Neutralization of TNF-α and IL-1β Regulates CXCL8 Production through CXCL8/CXCR1 Axis in Macrophages during Staphylococcus aureus Infection

References

• Absolom DR. 1986. Basic methods for the study of phagocytosis. Methods Enzymol. 132:95–180.
   PubMedGoogle Scholar
• Ali A, Welin A, Schwarze JC, Svensson MN, Na M, Jarneborn A, Magnusson M, Mohammad M, Kwiecinski J, Josefsson E, et al. 2015. CTLA4 immunoglobulin but not anti-tumor necrosis factor therapy promotes Staphylococcal septic arthritis in mice. J Infect Dis. 212(8):1308–16.
   PubMed Web of Science ®Google Scholar
• Ali T, Kaitha S, Mahmood S, Ftesi A, Stone J, Bronze MS. 2013. Clinical use of anti-TNF therapy and increased risk of infections. Drug Healthc Patient Saf. 5:79–99.
   PubMedGoogle Scholar
• Alves-Filho JC, Freitas A, Souto FO, Spiller F, Paula-Neto H, Silva JS, Gazzinelli RT, Teixeira MM, Ferreira SH, Cunha FQ. 2009. Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc Natl Acad Sci USA. 106(10):4018–23.
   PubMed Web of Science ®Google Scholar
• Baeuerle PA, Baltimore D. 1996. NF-kappa B: ten years after. Cell. 87(1):13–20.
   PubMed Web of Science ®Google Scholar
• Baeuerle PA, Henkel T. 1994. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 12:141–79.
   PubMed Web of Science ®Google Scholar
• Baltimore D. 2011. NF-κB is 25. Nat Immunol. 12(8):683–85.
   PubMed Web of Science ®Google Scholar
• Barrera P, Joosten LA, den Broeder AA, van de Putte LB, van Riel PL, van den Berg WB. 2001. Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNF alpha in patients with rheumatoid arthritis. Ann Rheum Dis. 60(7):660–69.
   PubMed Web of Science ®Google Scholar
• Beech JS, Wheeler DW, Reckless J, Grant AJ, Price J, Mastroeni P, Grainger DJ, Menon DK. 2007. The MHP36 line of murine neural stem cells expresses functional CXCR1 chemokine receptors that initiate chemotaxis in vitro. J Neuroimmunol. 184(1–2):198–208.
   PubMed Web of Science ®Google Scholar
• Beutler B, Cerami A. 1988. Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem. 57:505–18.
   PubMed Web of Science ®Google Scholar
• Bhavikatti SK, Alqahtani NA, Jyothsna SN, Prabhuji MLV, Moidin S, Paramashivaiah R. 2018. Anti-cytokine therapy: the newer horizons revisited. Int J Oral Care Res. 6(1):90–98.
   Google Scholar
• Bishayi B, Adhikary R, Sultana S, Dey R, Nandi A. 2017b. Altered expression of CXCR1 (IL-8R) in macrophages utilizing cell surface TNFR1 and IL-1 receptor during Staphylococcus aureus infection. Microb Pathog. 113:460–71.
   PubMed Web of Science ®Google Scholar
• Bishayi B, Bandyopadhyay D, Majhi A, Adhikary R. 2015. Expression of CXCR1 (Interleukin-8 Receptor) in murine macrophages after Staphylococcus aureus infection and its possible implication on intracellular survival correlating with cytokines and bacterial anti-oxidant enzymes. Inflammation. 38(2):812–27.
   PubMed Web of Science ®Google Scholar
• Bishayi B, Nandi A, Dey R, Adhikary R. 2017a. Expression of CXCR1 (IL-8 receptor A) in splenic, peritoneal macrophages and resident bone marrow cells after acute live or heat killed Staphylococcus aureus stimulation in mice. Microb Pathog. 109:131–50.
   PubMed Web of Science ®Google Scholar
• Borroni EM, Bonecchi R, Buracchi C, Savino B, Mantovani A, Locati M. 2008. Chemokine decoy receptors: new players in reproductive immunology. Immunol Invest. 37(5):483–97.
   PubMed Web of Science ®Google Scholar
• Bucher H, Mang S, Keck M, Przibilla M, Lamb DJ, Schiele F, Wittenbrink M, Fuchs K, Jung B, Erb KJ, et al. 2017. Neutralization of both IL-1α/IL-1β plays a major role in suppressing combined cigarette smoke/virus-induced pulmonary inflammation in mice. Pulm Pharmacol Ther. 44:96–105.
   PubMed Web of Science ®Google Scholar
• Carevic M, Öz H, Fuchs K, Laval J, Schroth C, Frey N, Hector A, Bilich T, Haug M, Schmidt A, et al. 2016. CXCR1 regulates pulmonary anti-pseudomonas host defense. J Innate Immun. 8(4):362–73.
   PubMed Web of Science ®Google Scholar
• Chan LP, Liu C, Chiang FY, Wang LF, Lee KW, Chen WT, Kuo PL, Liang CH. 2017. IL-8 promotes inflammatory mediators and stimulates activation of p38 MAPK/ERK-NF-κB pathway and reduction of JNK in HNSCC. Oncotarget. 8(34):56375–88.
   PubMedGoogle Scholar
• Clarke C, Kuboki S, Sakai N, Kasten KR, Tevar AD, Schuster R, Blanchard J, Caldwell CC, Edwards MJ, Lentsch AB. 2011. CXC chemokine receptor-1 is expressed by hepatocytes and regulates liver recovery after hepatic ischemia/reperfusion injury. Hepatology. 53(1):261–71.
   PubMed Web of Science ®Google Scholar
• Connelly L, Palacios-Callender M, Ameixa C, Moncada S, Hobbs AJ. 2001. Biphasic regulation of NF-kappa B activity underlies the pro- and anti-inflammatory actions of nitric oxide. J Immunol. 166(6):3873–81.
   PubMed Web of Science ®Google Scholar
• Cotton JA, Platnich JM, Muruve DA, Jijon HB, Buret AG, Beck PL. 2016. Interleukin-8 in gastrointestinal inflammation and malignancy: induction and clinical consequences. Int J Interferon Cytokine Mediat Res. 8:13–34.
   Google Scholar
• DeForge LE, Kenney JS, Jones ML, Warren JS, Remick DG. 1992. Biphasic production of IL-8 in lipopolysaccharide (LPS)-stimulated human whole blood. Separation of LPS and cytokine-stimulated components using anti-tumor necrosis factor and anti-IL-1 antibodies. J Immunol. 148(7):2133–41.
   PubMed Web of Science ®Google Scholar
• Dey S, Bishayi B. 2015. Killing of Staphylococcus aureus in murine macrophages by chloroquine used alone and in combination with ciprofloxacin or azithromycin. J Inflamm Res. 8:29–47.
   PubMed Web of Science ®Google Scholar
• Dinarello CA, Simon A, van der Meer JW. 2012. Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases. Nat Rev Drug Discov. 11(8):633–52.
   PubMed Web of Science ®Google Scholar
• Dorrington MG, Fraser IDC. 2019. NF-κB signaling in macrophages: dynamics, crosstalk, and signal integration. Front Immunol. 10:705.
   PubMed Web of Science ®Google Scholar
• Dutta P, Sultana S, Dey R, Bishayi B. 2019. Regulation of Staphylococcus aureus-induced CXCR1 expression via inhibition of receptor mobilization and receptor shedding during dual receptor (TNFR1 and IL-1R) neutralization. Immunol Res. 67(2–3):241–60.
   PubMed Web of Science ®Google Scholar
• Faggioni R, Fantuzzi G, Fuller J, Dinarello CA, Feingold KR, Grunfeld C. 1998. IL-1 beta mediates leptin induction during inflammation. Am J Physiol. 274(1):204–08.
   Web of Science ®Google Scholar
• Fallahi-Sichani M, Kirschner DE, Linderman JJ. 2012. NF-κB signaling dynamics play a key role in infection control in tuberculosis. Front Physiol. 3:170.
   PubMed Web of Science ®Google Scholar
• Fan XD, Patera AC, Pong-Kennedy A, Deno G, Gonsiorek W, Manfra DJ, Vassileva G, Zeng M, Jackson C, Sullivan L, et al. 2007. Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8. J Biol Chem. 282(16):11658–66.
   PubMed Web of Science ®Google Scholar
• Fei Y, Wang W, Kwiecinski J, Josefsson E, Pullerits R, Jonsson IM, Magnusson M, Jin T. 2011. The combination of a tumor necrosis factor inhibitor and antibiotic alleviates staphylococcal arthritis and sepsis in mice. J Infect Dis. 204(3):348–57.
   PubMed Web of Science ®Google Scholar
• Fong Y, Tracey KJ, Moldawer LL, Hesse DG, Manogue KB, Kenney JS, Lee AT, Kuo GC, Allison AC, Lowry SF, et al. 1989. Antibodies to cachectin/tumor necrosis factor reduce interleukin 1 beta and interleukin 6 appearances during lethal bacteremia. J Exp Med. 170(5):1627–33.
   PubMed Web of Science ®Google Scholar
• Gaupp R, Ledala N, Somerville GA. 2012. Staphylococcal response to oxidative stress. Front Cell Infect Microbiol. 2:33.
   PubMed Web of Science ®Google Scholar
• Graves DT, Cochran D. 2003. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol. 74(3):391–401.
   PubMed Web of Science ®Google Scholar
• Grossi V, Gulli F, Infantino M, Stefanile A, Napodano C, Benucci M, Pocino K, Gobbi FL, Damiani A, Pino AD, et al. 2020. The laboratory role in anti-TNF biological therapy era. Immunol Invest. 49(3):317–32.
   PubMed Web of Science ®Google Scholar
• Ha H, Debnath B, Neamati N. 2017. Role of the CXCL8-CXCR1/2 axis in cancer and inflammatory diseases. Theranostics. 7(6):1543–88.
   PubMed Web of Science ®Google Scholar
• Hayden MS, Ghosh S. 2004. Signaling to NF-kappaB. Genes Dev. 18(18):2195–224.
   PubMed Web of Science ®Google Scholar
• Hosokawa Y, Hosokawa I, Shindo S, Ozaki K, Matsuo T. 2017. IL-29 enhances CXCL10 production in TNF-α-stimulated human oral epithelial cells. Immunol Invest. 46(6):615–24.
   PubMed Web of Science ®Google Scholar
• Jayaraman P, Sada-Ovalle I, Nishimura T, Anderson AC, Kuchroo VK, Remold HG, Behar SM. 2013. IL-1β promotes antimicrobial immunity in macrophages by regulating TNFR signaling and caspase-3 activation. J Immunol. 190(8):4196–204.
   PubMed Web of Science ®Google Scholar
• Jia J, Sun Y, Hu Z, Li Y, Ruan X. 2017. Propofol inhibits the release of interleukin-6, 8 and tumor necrosis factor-α correlating with high-mobility group box 1 expression in lipopolysaccharides-stimulated RAW 264.7 cells. BMC Anesthesiol. 17(1):148.
   PubMedGoogle Scholar
• Kane TL, Carothers KE, Lee SW. 2018. Virulence factor targeting of the bacterial pathogen Staphylococcus aureus for vaccine and therapeutics. Curr Drug Targets. 19(2):111–27.
   PubMed Web of Science ®Google Scholar
• Karin M, Liu ZG, Zandi E. 1997. AP-1 function and regulation. Curr Opin Cell Biol. 9(2):240–46.
   PubMed Web of Science ®Google Scholar
• Koziel J, Maciag-Gudowska A, Mikolajczyk T, Bzowska M, Sturdevant DE, Whitney AR, Shaw LN, DeLeo FR, Potempa J. 2009. Phagocytosis of Staphylococcus aureus by macrophages exerts cytoprotective effects manifested by the upregulation of antiapoptotic factors. PLoS One. 4(4):e5210.
   PubMed Web of Science ®Google Scholar
• Krut O, Utermöhlen O, Schlossher X, Krönke M. 2003. Strain-specific association of cytotoxic activity and virulence of clinical Staphylococcus aureus isolates. Infect Immun. 71(5):2716–23.
   PubMed Web of Science ®Google Scholar
• Li Y, Si R, Feng Y, Chen HH, Zou L, Wang E, Zhang M, Warren HS, Sosnovik DE, Chao W. 2011. Myocardial ischemia activates an injurious innate immune signaling via cardiac heat shock protein 60 and toll-like receptor 4. J Biol Chem. 286(36):31308–19.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the follin phenol reagent. J Biol Chem. 193(1):265–75.
   PubMed Web of Science ®Google Scholar
• Maini RN, Taylor PC. 2000. Anti-cytokine therapy for rheumatoid arthritis. Annu Rev Med. 51:207–29.
   PubMed Web of Science ®Google Scholar
• Marino S, Sud D, Plessner H, Lin PL, Chan J, Flynn JL, Kirschner DE. 2007. Differences in reactivation of tuberculosis induced from anti-TNF treatments are based on bioavailability in granulomatous tissue. PLoS Comput Biol. 3(10):1909–24.
   PubMed Web of Science ®Google Scholar
• Martinet W, Schrijvers DM, Timmermans JP, Herman AG, De Meyer GR. 2009. Phagocytosis of bacteria is enhanced in macrophages undergoing nutrient deprivation. Febs J. 276(8):2227–40.
   PubMed Web of Science ®Google Scholar
• Matsunaga K, Klein TW, Friedman H, Yamamoto Y. 2001. Legionella pneumophila replication in macrophages inhibited by selective immunomodulatory effects on cytokine formation by epigallocatechin gallate, a major form of tea catechins. Infect Immun. 69(6):3947–53.
   PubMed Web of Science ®Google Scholar
• Matsushima K, Oppenheim JJ. 1989. Interleukin 8 and MCAF: novel inflammatory cytokines inducible by IL 1 and TNF. Cytokine. 1(1):2–13.
   PubMedGoogle Scholar
• Meduri GU, Kanangat S, Stefan J, Tolley E, Schaberg D. 1999. Cytokines IL-1β, IL-6, and TNF-α enhance in vitro growth of bacteria. Am J Respir Crit Care Med. 160(3):961–67.
   PubMed Web of Science ®Google Scholar
• Menaka KB, Ramesh A, Thomas B, Kumari NS. 2009. Estimation of nitric oxide as an inflammatory marker in periodontitis. J Indian Soc Periodontol. 13(2):75–78.
   PubMedGoogle Scholar
• Mirza RE, Fang MM, Ennis WJ, Koh TJ. 2013. Blocking interleukin-1β induces a healing-associated wound macrophage phenotype and improves healing in type 2 diabetes. Diabetes. 62(7):2579–87.
   PubMed Web of Science ®Google Scholar
• Na M, Wang W, Fei Y, Josefsson E, Ali A, Jin T. 2017. Both anti-TNF and CTLA4 Ig treatments attenuate the disease severity of staphylococcal dermatitis in mice. PLoS One. 12(3):e0173492.
   PubMed Web of Science ®Google Scholar
• Ostrov BE. 2015. Immunotherapeutic biologic agents in autoimmune and autoinflammatory diseases. Immunol Invest. 44(8):777–802.
   PubMed Web of Science ®Google Scholar
• Papa S, Zazzeroni F, Pham CG, Bubici C, Franzoso G. 2004. Linking JNK signaling to NF-kappaB: a key to survival. J Cell Sci. 117:5197–208.
   PubMed Web of Science ®Google Scholar
• Ransohoff R. 2007. Letter to the Editor; The MHP36 line of murine neural stem cells expresses functional CXCR1 chemokine receptors that initiate chemotaxis in vitro. J Neuroimmunol. 186:99.
   Web of Science ®Google Scholar
• Russo RC, Garcia CC, Teixeira MM, Amaral FA. 2014. The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases. Expert Rev Clin Immunol. 10(5):593–619.
   PubMed Web of Science ®Google Scholar
• Sano H, Hsu DK, Apgar JR, Yu L, Sharma BB, Kuwabara I, Izui S, Liu FT. 2003. Critical role of galectin-3 in phagocytosis by macrophages. J Clin Invest. 112(3):389–97.
   PubMed Web of Science ®Google Scholar
• Sherry B, Dai WW, Lesser ML, Trachtman H. 2008. Dysregulated chemokine receptor expression and chemokine-mediated cell trafficking in pediatric patients with ESRD. Clin J Am Soc Nephrol. 3(2):397–406.
   PubMed Web of Science ®Google Scholar
• Srivastava KD, Rom WN, Jagirdar J, Yie TA, Gordon T, Tchou-Wong KM. 2002. Crucial role of interleukin-1beta and nitric oxide synthase in silica-induced inflammation and apoptosis in mice. Am J Respir Crit Care Med. 165(4):527–33.
   PubMed Web of Science ®Google Scholar
• Stokes DG, Kremer JM. 2003. Potential of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis. Semin Arthritis Rheum. 33(1):1–18.
   PubMed Web of Science ®Google Scholar
• Trivedi PJ, Adams DH. 2018. Chemokines and chemokine receptors as therapeutic targets in inflammatory bowel disease; pitfalls and promise. J Crohns Colitis. 12(12):1508.
   PubMed Web of Science ®Google Scholar
• Turner MD, Nedjai B, Hurst T, Pennington DJ. 2014. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochim Biophys Acta. 1843(11):2563–82.
   PubMed Web of Science ®Google Scholar
• Wang C, Yu X, Cao Q, Wang Y, Zheng G, Tan TK, Zhao H, Zhao Y, Wang Y, Harris D. 2013. Characterization of murine macrophages from bone marrow, spleen and peritoneum. BMC Immunol. 14:6–16.
   PubMed Web of Science ®Google Scholar
• Watanabe I, Ichiki M, Shiratsuchi A, Nakanishi Y. 2007. TLR2-mediated survival of Staphylococcus aureus in macrophages: a novel bacterial strategy against host innate immunity. J Immunol. 178(8):4917–25.
   PubMed Web of Science ®Google Scholar
• Yao L, Berman JW, Factor SM, Lowy FD. 1997. Correlation of histopathologic and bacteriologic changes in experimental murine model of bacteremic Staphylococcus aureus infection. Infect Immun. 65(9):3889–95.
   PubMed Web of Science ®Google Scholar